Skip to main content
Clinical Trials/NCT04772066
NCT04772066
Unknown
Not Applicable

Evaluation of Tools to Assess Medication Adherence

University Hospital, Montpellier1 site in 1 country600 target enrollmentNovember 1, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Medication Adherence
Sponsor
University Hospital, Montpellier
Enrollment
600
Locations
1
Primary Endpoint
MA according to Medication Possession Ratio (MPR) calculation
Last Updated
5 years ago

Overview

Brief Summary

The issue of medication adherence (MA) has long been undestimated but is now growing interest due to both the increase of patients with chronic diseases and the aging of the population. According to the World Health Organization, only 50% of patients with chronic illnesses correctly follow physician's prescriptions in developed countries. Beyond the individual consequences that failure to adherence can engender (increased morbidity, mortality and hospitalizations), this concept also encompasses a collective dimension (risk of transmission of infectious diseases and increased health care costs). Today, improving MA would have more impact on human health than developping new medical therapies. That's why detecting non-adherence constitutes a major public health issue in which pharmacists play a significant role through medication reconciliation and patients' education.

The methods wildly used are based on indirect measurement: questionnaires completed by the patient himself or the Medication Possession Ratio (MPR). Each method has its own advantages and disadvantages, but none is considered as the gold standard. The Montpellier University Hospital set up a MA self-report scale ranging from 0 (low) to 10 (high adherence) in the various care units where the clinical pharmacy activity is deployed.

The purpose of this study was to assess the MA according to this numerical scale and the MPR calculation, and evaluate the correlation between these two methods.

Registry
clinicaltrials.gov
Start Date
November 1, 2019
End Date
December 30, 2021
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

MA according to Medication Possession Ratio (MPR) calculation

Time Frame: 1 day

MA according to Medication Possession Ratio (MPR) calculation

Self-reported MA according to self-reported medication adherence scale

Time Frame: 1 day

Self-reported MA according to self-reported MA scale : The self-report scale ranges from 0 (low) to 10 (high adherence)

Secondary Outcomes

  • Variables associated with medication non-adherence(1 day)
  • Number of patients with medication non-adherence according to self-reported MA scale and MPR calculation(1 day)

Study Sites (1)

Loading locations...

Similar Trials